Human, canine and murine BRCA1 genes: sequence comparison among species.
暂无分享,去创建一个
M. King | E. Ostrander | C. Szabo | R. Argonza | L. Wagner | J. Roach | L. Francisco
[1] M. Skolnick,et al. Comparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populations. , 1996, Human molecular genetics.
[2] J. Rommens,et al. BRCA2 germline mutations in male breast cancer cases and breast cancer families , 1996, Nature Genetics.
[3] J. Eyfjörd,et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes , 1996, Nature Genetics.
[4] Kenneth Offit,et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer , 1996, Nature Genetics.
[5] M. King,et al. Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. , 1996, American journal of human genetics.
[6] J. Rommens,et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds , 1996, Nature Genetics.
[7] M. King,et al. BRCA1 is secreted and exhibits properties of a granin , 1996, Nature Genetics.
[8] B. Ponder,et al. Rapid detection of regionally clustered germ-line BRCA1 mutations by multiplex heteroduplex analysis. UKCCCR Familial Ovarian Cancer Study Group. , 1996, American journal of human genetics.
[9] M. King,et al. Growth retardation and tumour inhibition by BRCA1 , 1996, Nature Genetics.
[10] Julian Peto,et al. Identification of the breast cancer susceptibility gene BRCA2 , 1996, Nature.
[11] Barbara L. Smith,et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. , 1996, The New England journal of medicine.
[12] J. D. Thompson,et al. BRCA1 mutations in a population-based sample of young women with breast cancer. , 1996, The New England journal of medicine.
[13] A. Bradley,et al. Murine Brca1: sequence and significance for human missense mutations. , 1995, Human molecular genetics.
[14] D. Clayton,et al. Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation , 1995, Nature Genetics.
[15] B. Weber,et al. Mouse Brca1: localization sequence analysis and identification of evolutionarily conserved domains. , 1995, Human molecular genetics.
[16] M. King,et al. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. , 1995, American journal of human genetics.
[17] J. Gudmundsson,et al. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. , 1995, Cancer research.
[18] P. Devilee,et al. Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. , 1995, British Journal of Cancer.
[19] P. Leder,et al. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. , 1995, Genes & development.
[20] L. Bennett,et al. Isolation of the mouse homologue of BRCA1 and genetic mapping to mouse chromosome 11. , 1995, Genomics.
[21] M. Goodson,et al. Tissue-dependent expression of heat shock factor 2 isoforms with distinct transcriptional activities , 1995, Molecular and cellular biology.
[22] M. King,et al. Inherited breast and ovarian cancer. , 1995, Human molecular genetics.
[23] T. Sugimura,et al. Germline mutation of BRCA1 in Japanese breast cancer families. , 1995, Cancer research.
[24] D. Birnbaum,et al. Patterns of loss of heterozygosity at loci from chromosome arm 13q suggest a possible involvement of BRCA2 in sporadic breast tumors , 1995, Genes, chromosomes & cancer.
[25] M. King,et al. Mutation analysis of the BRCA1 gene in ovarian cancers. , 1995, Cancer research.
[26] David L. Page,et al. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression , 1995, Nature Genetics.
[27] A. Jeffreys,et al. A somatic BRCA1 mutation in an ovarian tumour , 1995, Nature Genetics.
[28] M. Skolnick,et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. , 1995, JAMA.
[29] M. King,et al. The search for BRCA1. , 1994, Cancer research.
[30] Patrick Dowd,et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families , 1994, Nature Genetics.
[31] J. Rommens,et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families , 1994, Nature Genetics.
[32] S. Neuhausen,et al. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. , 1994, Cancer Research.
[33] Francis S. Collins,et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer , 1994, Nature Genetics.
[34] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[35] M. Skolnick,et al. BRCA1 mutations in primary breast and ovarian carcinomas. , 1994, Science.
[36] S. Seal,et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. , 1994, Science.
[37] T. Jacks,et al. Cooperative tumorigenic effects of germline mutations in Rb and p53 , 1994, Nature Genetics.
[38] Y. Wan,et al. Expression of activin receptor II and IIB mRNA isoforms in mouse reproductive organs and oocytes , 1994, Molecular reproduction and development.
[39] P. Koopman,et al. Alternative splicing of the first nucleotide binding fold of CFTR in mouse testes is associated with specific stages of spermatogenesis. , 1994, Genomics.
[40] A. Bradley,et al. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. , 1994, Oncogene.
[41] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.
[42] R. Weinberg,et al. Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.
[43] R. Lidereau,et al. Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted. , 1993, Cancer research.
[44] E. Lander,et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse , 1993, Cell.
[45] G. Michael,et al. Alpha 2-chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternate splicing of the human n-chimerin gene, is selectively expressed in brain regions and testes , 1993, Molecular and cellular biology.
[46] M. Carcangiu,et al. Allelic loss in ovarian cancer , 1993, International journal of cancer.
[47] W D Flanders,et al. The lifetime risk of developing breast cancer. , 1993, Journal of the National Cancer Institute.
[48] L. Hartmann,et al. Human epithelial ovarian cancer allelotype. , 1993, Cancer research.
[49] J. Rine,et al. Identification and characterization of dinucleotide repeat (CA)n markers for genetic mapping in dog. , 1993, Genomics.
[50] D. Easton,et al. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.
[51] R. Lovering,et al. Identification and preliminary characterization of a protein motif related to the zinc finger. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[52] S. Henikoff,et al. Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[53] A. Joyner,et al. A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. , 1992, Genes & development.
[54] L. Donehower,et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.
[55] P. S. Kim,et al. X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. , 1991, Science.
[56] H. Kondoh,et al. Embryonic lethality resulting from disruption of both N-myc alleles in mouse zygotes. , 1991, The New biologist.
[57] R. W. Davis,et al. Lambda YES: a multifunctional cDNA expression vector for the isolation of genes by complementation of yeast and Escherichia coli mutations. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[58] Allan Bradley,et al. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.
[59] N Risch,et al. Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.
[60] M. King,et al. Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.
[61] W. Lowry,et al. Allele loss from chromosome 17 in ovarian cancer. , 1990, Oncogene.
[62] B. Gusterson,et al. Comparative study of human and rat mammary tumorigenesis. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[63] M. Frohman,et al. Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[64] T. Doetschman,et al. Targeted mutation of the Hprt gene in mouse embryonic stem cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[65] M. King,et al. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[66] J. Moulton,et al. Mammary Tumors in a Colony of Beagle Dogs , 1986, Veterinary pathology.
[67] D. Givol,et al. Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells. , 1985, The EMBO journal.
[68] William D. Richardson,et al. A short amino acid sequence able to specify nuclear location , 1984, Cell.
[69] E. Macewen,et al. Estrogen receptors in canine mammary tumors. , 1982, Cancer research.
[70] Owen Ln. A comparative study of canine and human breast cancer. , 1979 .
[71] C. W. Mays,et al. Mammary neoplasia in a closed beagle colony. , 1976, Cancer research.
[72] J. Reif,et al. Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. , 1974, Cancer research.
[73] D. Goodman,et al. Animal model of human disease: canine mammary neoplasia. , 1974, The American journal of pathology.
[74] M. Klauber,et al. Survey of animal neoplasms in Alameda and Contra Costa Counties, California. II. Cancer morbidity in dogs and cats from Alameda County. , 1968, Journal of the National Cancer Institute.
[75] I. Fidler,et al. The biological behavior of canine mammary neoplasms. , 1967, Journal of the American Veterinary Medical Association.
[76] I. Fidler,et al. A necropsy study of canine malignant mammary neoplasms. , 1967, Journal of the American Veterinary Medical Association.
[77] P. Tonin,et al. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. , 1996, American Journal of Human Genetics.
[78] C. Larsson,et al. Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families , 1996, Nature Genetics.
[79] F. Collins,et al. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. , 1995, American journal of human genetics.
[80] F. Collins,et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours , 1995, Nature Genetics.
[81] J. Klijn,et al. Rapid detection of BRCA1 mutations by the protein truncation test , 1995, Nature Genetics.
[82] A. Baxevanis,et al. Interactions of coiled coils in transcription factors: where is the specificity? , 1993, Current opinion in genetics & development.
[83] P. Freemont. The RING finger. A novel protein sequence motif related to the zinc finger. , 1993, Annals of the New York Academy of Sciences.
[84] Y. Nakamura,et al. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. , 1993, Cancer research.
[85] W. Huttner,et al. The granin (chromogranin/secretogranin) family. , 1991, Trends in biochemical sciences.
[86] C. J. Avers. Process and pattern in evolution , 1989 .
[87] L. Owen. A comparative study of canine and human breast cancer. , 1979, Investigative & cell pathology.